

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 6.43335259 |
| 2 | polyketide metabolic process (GO:0030638) | 6.43335259 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.43335259 |
| 4 | cullin deneddylation (GO:0010388) | 5.70183907 |
| 5 | protein deneddylation (GO:0000338) | 5.25577855 |
| 6 | DNA double-strand break processing (GO:0000729) | 4.71082274 |
| 7 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.23998137 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.22698483 |
| 9 | protein complex biogenesis (GO:0070271) | 4.19231156 |
| 10 | protein neddylation (GO:0045116) | 4.19046199 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.11738312 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 4.11738312 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.11738312 |
| 14 | establishment of integrated proviral latency (GO:0075713) | 4.09103660 |
| 15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.02750831 |
| 16 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.02367150 |
| 17 | transferrin transport (GO:0033572) | 3.99387675 |
| 18 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.98441958 |
| 19 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.98441958 |
| 20 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.88138156 |
| 21 | ATP synthesis coupled proton transport (GO:0015986) | 3.88138156 |
| 22 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.85639434 |
| 23 | phagosome maturation (GO:0090382) | 3.79467271 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.79442382 |
| 25 | ribosome assembly (GO:0042255) | 3.73299683 |
| 26 | electron transport chain (GO:0022900) | 3.68453516 |
| 27 | respiratory electron transport chain (GO:0022904) | 3.66647126 |
| 28 | trivalent inorganic cation transport (GO:0072512) | 3.66164666 |
| 29 | ferric iron transport (GO:0015682) | 3.66164666 |
| 30 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.63950828 |
| 31 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.63938159 |
| 32 | signal peptide processing (GO:0006465) | 3.60183921 |
| 33 | CENP-A containing nucleosome assembly (GO:0034080) | 3.58267188 |
| 34 | chromatin remodeling at centromere (GO:0031055) | 3.57191913 |
| 35 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.57150702 |
| 36 | respiratory chain complex IV assembly (GO:0008535) | 3.51492177 |
| 37 | mitotic metaphase plate congression (GO:0007080) | 3.46800100 |
| 38 | positive regulation of ligase activity (GO:0051351) | 3.46756576 |
| 39 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.40586669 |
| 40 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.40586669 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.40500956 |
| 42 | metaphase plate congression (GO:0051310) | 3.40221985 |
| 43 | rRNA methylation (GO:0031167) | 3.39602581 |
| 44 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.39526320 |
| 45 | mitochondrial DNA replication (GO:0006264) | 3.38139013 |
| 46 | proteasome assembly (GO:0043248) | 3.37891205 |
| 47 | GDP-mannose metabolic process (GO:0019673) | 3.35805646 |
| 48 | interferon-gamma production (GO:0032609) | 3.34829301 |
| 49 | protein localization to cilium (GO:0061512) | 3.31923201 |
| 50 | establishment of viral latency (GO:0019043) | 3.31042443 |
| 51 | intestinal epithelial cell development (GO:0060576) | 3.29627624 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.28281065 |
| 53 | rRNA modification (GO:0000154) | 3.28276793 |
| 54 | regulation of meiosis I (GO:0060631) | 3.27159098 |
| 55 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.27144372 |
| 56 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.26594871 |
| 57 | quinone metabolic process (GO:1901661) | 3.25877930 |
| 58 | DNA damage response, detection of DNA damage (GO:0042769) | 3.19631214 |
| 59 | regulation of ligase activity (GO:0051340) | 3.19182849 |
| 60 | inositol phosphate catabolic process (GO:0071545) | 3.17220488 |
| 61 | protein-cofactor linkage (GO:0018065) | 3.16386977 |
| 62 | regulation of guanylate cyclase activity (GO:0031282) | 3.16267653 |
| 63 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.14238606 |
| 64 | negative regulation of DNA recombination (GO:0045910) | 3.14042182 |
| 65 | purine nucleobase biosynthetic process (GO:0009113) | 3.09900153 |
| 66 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.07152622 |
| 67 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.07152622 |
| 68 | histone exchange (GO:0043486) | 3.07013014 |
| 69 | regulation of cilium movement (GO:0003352) | 3.05995922 |
| 70 | spindle checkpoint (GO:0031577) | 3.05334184 |
| 71 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.05143610 |
| 72 | mitotic spindle checkpoint (GO:0071174) | 3.03747972 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.03349378 |
| 74 | neurotransmitter uptake (GO:0001504) | 3.00881650 |
| 75 | histone mRNA metabolic process (GO:0008334) | 2.99096662 |
| 76 | DNA ligation (GO:0006266) | 2.99039909 |
| 77 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.96678772 |
| 78 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95260152 |
| 79 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94666342 |
| 80 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94666342 |
| 81 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.93470493 |
| 82 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93138021 |
| 83 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92449860 |
| 84 | positive regulation of mitochondrial fission (GO:0090141) | 2.91447055 |
| 85 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.90646628 |
| 86 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.90430314 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.89994577 |
| 88 | cellular glucuronidation (GO:0052695) | 2.89269198 |
| 89 | regulation of cellular amine metabolic process (GO:0033238) | 2.89018187 |
| 90 | protein K11-linked ubiquitination (GO:0070979) | 2.88796743 |
| 91 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.85854107 |
| 92 | viral protein processing (GO:0019082) | 2.85674130 |
| 93 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.85540139 |
| 94 | glucuronate metabolic process (GO:0019585) | 2.84866878 |
| 95 | uronic acid metabolic process (GO:0006063) | 2.84866878 |
| 96 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.84801939 |
| 97 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.84801939 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84775719 |
| 99 | neuronal action potential propagation (GO:0019227) | 2.84754464 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.84412717 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.84412717 |
| 102 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.84166050 |
| 103 | negative regulation of sister chromatid segregation (GO:0033046) | 2.84166050 |
| 104 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.84166050 |
| 105 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.84166050 |
| 106 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.84166050 |
| 107 | glycoside metabolic process (GO:0016137) | 2.84149354 |
| 108 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83821922 |
| 109 | lactate metabolic process (GO:0006089) | 2.83697137 |
| 110 | negative regulation of protein ubiquitination (GO:0031397) | 2.83157882 |
| 111 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.82993312 |
| 112 | pseudouridine synthesis (GO:0001522) | 2.82521582 |
| 113 | hydrogen ion transmembrane transport (GO:1902600) | 2.81642123 |
| 114 | establishment of chromosome localization (GO:0051303) | 2.81159056 |
| 115 | peptidyl-cysteine modification (GO:0018198) | 2.79602849 |
| 116 | protein localization to kinetochore (GO:0034501) | 2.79236491 |
| 117 | cytidine metabolic process (GO:0046087) | 2.78659328 |
| 118 | cytidine catabolic process (GO:0006216) | 2.78659328 |
| 119 | cytidine deamination (GO:0009972) | 2.78659328 |
| 120 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77794780 |
| 121 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77794780 |
| 122 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77794780 |
| 123 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.76359151 |
| 124 | regulation of sister chromatid segregation (GO:0033045) | 2.74705376 |
| 125 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.74705376 |
| 126 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.74705376 |
| 127 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.73473383 |
| 128 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.73473383 |
| 129 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.73473383 |
| 130 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.72921723 |
| 131 | melanosome transport (GO:0032402) | 2.72774150 |
| 132 | inositol phosphate dephosphorylation (GO:0046855) | 2.72710734 |
| 133 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.72710734 |
| 134 | dopamine transport (GO:0015872) | 2.72655771 |
| 135 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.71780540 |
| 136 | negative regulation of chromosome segregation (GO:0051985) | 2.71714314 |
| 137 | negative regulation of ligase activity (GO:0051352) | 2.71475300 |
| 138 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71475300 |
| 139 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.70894913 |
| 140 | isotype switching (GO:0045190) | 2.70894913 |
| 141 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.70894913 |
| 142 | proton transport (GO:0015992) | 2.69546581 |
| 143 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.68786178 |
| 144 | DNA replication-independent nucleosome organization (GO:0034724) | 2.68786178 |
| 145 | synaptic vesicle exocytosis (GO:0016079) | 2.68225799 |
| 146 | protein targeting to mitochondrion (GO:0006626) | 2.66427646 |
| 147 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.65846552 |
| 148 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.64551989 |
| 149 | establishment of melanosome localization (GO:0032401) | 2.64200909 |
| 150 | non-recombinational repair (GO:0000726) | 2.64110165 |
| 151 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.64110165 |
| 152 | hydrogen transport (GO:0006818) | 2.63857323 |
| 153 | NADH metabolic process (GO:0006734) | 2.61903664 |
| 154 | pigment granule transport (GO:0051904) | 2.60786569 |
| 155 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.59204117 |
| 156 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.59204117 |
| 157 | cellular component biogenesis (GO:0044085) | 2.57642655 |
| 158 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.54438247 |
| 159 | presynaptic membrane assembly (GO:0097105) | 2.54337590 |
| 160 | establishment of pigment granule localization (GO:0051905) | 2.53147911 |
| 161 | regulation of axon regeneration (GO:0048679) | 2.49619921 |
| 162 | regulation of neuron projection regeneration (GO:0070570) | 2.49619921 |
| 163 | positive regulation of TOR signaling (GO:0032008) | 2.48799651 |
| 164 | melanosome localization (GO:0032400) | 2.48661447 |
| 165 | establishment of protein localization to mitochondrion (GO:0072655) | 2.46063102 |
| 166 | detection of temperature stimulus (GO:0016048) | 2.45716560 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.44218269 |
| 168 | neutrophil activation involved in immune response (GO:0002283) | 2.43301642 |
| 169 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.42737099 |
| 170 | cotranslational protein targeting to membrane (GO:0006613) | 2.42201969 |
| 171 | rRNA transcription (GO:0009303) | 2.41166023 |
| 172 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.39927324 |
| 173 | pigment granule localization (GO:0051875) | 2.39177010 |
| 174 | regulation of mitochondrial translation (GO:0070129) | 2.37265650 |
| 175 | GTP biosynthetic process (GO:0006183) | 2.37175882 |
| 176 | cyclooxygenase pathway (GO:0019371) | 2.36948323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 6.16735341 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.05546193 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.34144234 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.85284611 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.39061455 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.07356670 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.91357994 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.89647913 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.84165527 |
| 10 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.67987920 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52145032 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.46151802 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.40356859 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.36617947 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.23578702 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.18543528 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.16521118 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11712420 |
| 19 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.00854701 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95531948 |
| 21 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.95182999 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94954870 |
| 23 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.91257105 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90325526 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.90154584 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87921175 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.87019051 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85844892 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84800335 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.84626711 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82256480 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80935319 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.79721922 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79480091 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78702735 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.76555053 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72607988 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72008233 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71950135 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71830440 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.69878163 |
| 42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.69756647 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68953090 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.65998402 |
| 45 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.65998402 |
| 46 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.65998402 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.63046920 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61665423 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59168877 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52692365 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52365829 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49317275 |
| 53 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.47509693 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45858869 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45803110 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44993118 |
| 57 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39187056 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.38574113 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37847022 |
| 60 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.37004355 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36181864 |
| 62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.35466173 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34547869 |
| 64 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.33667726 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33092628 |
| 66 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.32675416 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32652452 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24286470 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22195274 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22034646 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20149589 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19698354 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19541825 |
| 74 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17129538 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17044634 |
| 76 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16713629 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16170192 |
| 78 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15980581 |
| 79 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15799470 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15046006 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14381140 |
| 82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12702552 |
| 83 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.12611440 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12414094 |
| 85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11930579 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11435271 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11341033 |
| 88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10796168 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10411199 |
| 90 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.10355206 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09099828 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 1.09057598 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08136305 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07965066 |
| 95 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.06845259 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06416498 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06377451 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05346118 |
| 99 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04875863 |
| 100 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03179518 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02771183 |
| 102 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.02701066 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00886379 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00826477 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00285077 |
| 106 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.99460568 |
| 107 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99042582 |
| 108 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98934329 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98255942 |
| 110 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97676776 |
| 111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97676776 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97163908 |
| 113 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96997915 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96997915 |
| 115 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96363047 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96324127 |
| 117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96219973 |
| 118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96043502 |
| 119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96042517 |
| 120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94735408 |
| 121 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.94506135 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92556814 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92151809 |
| 124 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91950184 |
| 125 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91818824 |
| 126 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.91608976 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91600226 |
| 128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91538367 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90762997 |
| 130 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90057707 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88498975 |
| 132 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86143939 |
| 133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85520204 |
| 134 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84930110 |
| 135 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84269889 |
| 136 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.83141841 |
| 137 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82601412 |
| 138 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.81993973 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81879050 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81879050 |
| 141 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81521611 |
| 142 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.81473799 |
| 143 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.81178140 |
| 144 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.79577121 |
| 145 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79260949 |
| 146 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.78621336 |
| 147 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.77250749 |
| 148 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.76935563 |
| 149 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76761540 |
| 150 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75779831 |
| 151 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75337534 |
| 152 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.75191943 |
| 153 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74878854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.00166159 |
| 2 | MP0003718_maternal_effect | 3.88325387 |
| 3 | MP0002102_abnormal_ear_morphology | 3.67852951 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.46025720 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.41016902 |
| 6 | MP0003880_abnormal_central_pattern | 3.34480585 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.16743701 |
| 8 | MP0003941_abnormal_skin_development | 3.00644456 |
| 9 | MP0003122_maternal_imprinting | 2.99389618 |
| 10 | MP0002736_abnormal_nociception_after | 2.90940769 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.90387739 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.89244388 |
| 13 | MP0008058_abnormal_DNA_repair | 2.89045645 |
| 14 | MP0009046_muscle_twitch | 2.72033392 |
| 15 | MP0001905_abnormal_dopamine_level | 2.63047172 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.62656322 |
| 17 | MP0003724_increased_susceptibility_to | 2.59258778 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.54957954 |
| 19 | MP0005360_urolithiasis | 2.45502720 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.36746687 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.35415907 |
| 22 | MP0003011_delayed_dark_adaptation | 2.32523833 |
| 23 | MP0002064_seizures | 2.31186441 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 2.16420294 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 2.16004502 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.15565069 |
| 27 | MP0009745_abnormal_behavioral_response | 2.14152528 |
| 28 | MP0004142_abnormal_muscle_tone | 2.10561389 |
| 29 | MP0010094_abnormal_chromosome_stability | 2.08752006 |
| 30 | MP0008932_abnormal_embryonic_tissue | 2.08699729 |
| 31 | MP0004270_analgesia | 2.08261390 |
| 32 | MP0001986_abnormal_taste_sensitivity | 2.05593317 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 2.03407161 |
| 34 | MP0001501_abnormal_sleep_pattern | 2.01750736 |
| 35 | MP0008057_abnormal_DNA_replication | 2.00432616 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.97151386 |
| 37 | MP0009785_altered_susceptibility_to | 1.94503119 |
| 38 | MP0005671_abnormal_response_to | 1.93439225 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.92962419 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.90325400 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.87638776 |
| 42 | MP0004858_abnormal_nervous_system | 1.87576501 |
| 43 | MP0002272_abnormal_nervous_system | 1.87464167 |
| 44 | MP0006054_spinal_hemorrhage | 1.84652498 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.83334657 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.82430432 |
| 47 | MP0004859_abnormal_synaptic_plasticity | 1.82424029 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.81418889 |
| 49 | MP0001529_abnormal_vocalization | 1.81330767 |
| 50 | MP0005394_taste/olfaction_phenotype | 1.79312614 |
| 51 | MP0005499_abnormal_olfactory_system | 1.79312614 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 1.79058257 |
| 53 | MP0006082_CNS_inflammation | 1.78387386 |
| 54 | MP0001970_abnormal_pain_threshold | 1.78175347 |
| 55 | MP0003111_abnormal_nucleus_morphology | 1.76703263 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.75887466 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.75885888 |
| 58 | MP0003786_premature_aging | 1.72233510 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.71956059 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.71929286 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.65264933 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.64410779 |
| 63 | MP0001188_hyperpigmentation | 1.60468139 |
| 64 | MP0000427_abnormal_hair_cycle | 1.56576765 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.53089162 |
| 66 | MP0003077_abnormal_cell_cycle | 1.51978111 |
| 67 | MP0005171_absent_coat_pigmentation | 1.45937448 |
| 68 | MP0001293_anophthalmia | 1.45885558 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.45569596 |
| 70 | MP0005365_abnormal_bile_salt | 1.42659788 |
| 71 | MP0005367_renal/urinary_system_phenotyp | 1.42489142 |
| 72 | MP0000516_abnormal_urinary_system | 1.42489142 |
| 73 | MP0005395_other_phenotype | 1.42435482 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.41679073 |
| 75 | MP0001542_abnormal_bone_strength | 1.39627745 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.39323592 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 1.38088366 |
| 78 | MP0002796_impaired_skin_barrier | 1.37949772 |
| 79 | MP0001764_abnormal_homeostasis | 1.36275669 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 1.35141785 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.33515797 |
| 82 | MP0003787_abnormal_imprinting | 1.32872011 |
| 83 | MP0003436_decreased_susceptibility_to | 1.32758538 |
| 84 | MP0005332_abnormal_amino_acid | 1.32359459 |
| 85 | MP0003252_abnormal_bile_duct | 1.31109357 |
| 86 | MP0002067_abnormal_sensory_capabilities | 1.30645851 |
| 87 | MP0005310_abnormal_salivary_gland | 1.29089411 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.27322006 |
| 89 | MP0001485_abnormal_pinna_reflex | 1.25222045 |
| 90 | MP0000647_abnormal_sebaceous_gland | 1.22687211 |
| 91 | MP0003123_paternal_imprinting | 1.18156158 |
| 92 | MP0004043_abnormal_pH_regulation | 1.17564216 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.16391145 |
| 94 | MP0010678_abnormal_skin_adnexa | 1.15896784 |
| 95 | MP0003937_abnormal_limbs/digits/tail_de | 1.13103666 |
| 96 | MP0004215_abnormal_myocardial_fiber | 1.12364798 |
| 97 | MP0001486_abnormal_startle_reflex | 1.12214515 |
| 98 | MP0002938_white_spotting | 1.11807188 |
| 99 | MP0005646_abnormal_pituitary_gland | 1.11493789 |
| 100 | MP0005025_abnormal_response_to | 1.10882507 |
| 101 | MP0010307_abnormal_tumor_latency | 1.09096211 |
| 102 | MP0002163_abnormal_gland_morphology | 1.09005755 |
| 103 | MP0001730_embryonic_growth_arrest | 1.08981420 |
| 104 | MP0003119_abnormal_digestive_system | 1.06639697 |
| 105 | MP0003121_genomic_imprinting | 1.05408639 |
| 106 | MP0001929_abnormal_gametogenesis | 1.05391920 |
| 107 | MP0000490_abnormal_crypts_of | 1.05005534 |
| 108 | MP0001348_abnormal_lacrimal_gland | 1.04480098 |
| 109 | MP0001440_abnormal_grooming_behavior | 1.04185924 |
| 110 | MP0003879_abnormal_hair_cell | 1.03450019 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 1.02796930 |
| 112 | MP0008260_abnormal_autophagy | 1.01655773 |
| 113 | MP0002132_abnormal_respiratory_system | 1.00798381 |
| 114 | MP0002098_abnormal_vibrissa_morphology | 1.00498118 |
| 115 | MP0001984_abnormal_olfaction | 0.97502745 |
| 116 | MP0003186_abnormal_redox_activity | 0.95606591 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.95237400 |
| 118 | MP0002210_abnormal_sex_determination | 0.94965091 |
| 119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93139315 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.91550698 |
| 121 | MP0002723_abnormal_immune_serum | 0.90871890 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.90688524 |
| 123 | MP0000653_abnormal_sex_gland | 0.90554188 |
| 124 | MP0001819_abnormal_immune_cell | 0.90151227 |
| 125 | MP0002254_reproductive_system_inflammat | 0.90148647 |
| 126 | MP0005387_immune_system_phenotype | 0.89697738 |
| 127 | MP0001790_abnormal_immune_system | 0.89697738 |
| 128 | MP0002233_abnormal_nose_morphology | 0.87688627 |
| 129 | MP0000749_muscle_degeneration | 0.87446136 |
| 130 | MP0002419_abnormal_innate_immunity | 0.86306466 |
| 131 | MP0004957_abnormal_blastocyst_morpholog | 0.85527514 |
| 132 | MP0003868_abnormal_feces_composition | 0.85279816 |
| 133 | MP0000920_abnormal_myelination | 0.84622393 |
| 134 | MP0001145_abnormal_male_reproductive | 0.83965105 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.83844129 |
| 136 | MP0002084_abnormal_developmental_patter | 0.82882352 |
| 137 | MP0000358_abnormal_cell_content/ | 0.82650132 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82467956 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.82353955 |
| 140 | MP0002090_abnormal_vision | 0.82231642 |
| 141 | MP0005501_abnormal_skin_physiology | 0.80360764 |
| 142 | MP0005253_abnormal_eye_physiology | 0.80173137 |
| 143 | MP0005410_abnormal_fertilization | 0.79951881 |
| 144 | MP0002184_abnormal_innervation | 0.79329220 |
| 145 | MP0004811_abnormal_neuron_physiology | 0.78518252 |
| 146 | MP0001697_abnormal_embryo_size | 0.76819820 |
| 147 | MP0004147_increased_porphyrin_level | 0.76662253 |
| 148 | MP0000343_altered_response_to | 0.76522774 |
| 149 | MP0009697_abnormal_copulation | 0.75708963 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.75252174 |
| 151 | MP0002234_abnormal_pharynx_morphology | 0.75070400 |
| 152 | MP0002452_abnormal_antigen_presenting | 0.74361691 |
| 153 | MP0004381_abnormal_hair_follicle | 0.73126654 |
| 154 | MP0002909_abnormal_adrenal_gland | 0.73082961 |
| 155 | MP0001119_abnormal_female_reproductive | 0.71305167 |
| 156 | MP0001672_abnormal_embryogenesis/_devel | 0.71084536 |
| 157 | MP0005380_embryogenesis_phenotype | 0.71084536 |
| 158 | MP0003195_calcinosis | 0.71068771 |
| 159 | MP0008569_lethality_at_weaning | 0.68728852 |
| 160 | MP0000049_abnormal_middle_ear | 0.68419089 |
| 161 | MP0001727_abnormal_embryo_implantation | 0.68367761 |
| 162 | MP0001800_abnormal_humoral_immune | 0.67975895 |
| 163 | MP0008004_abnormal_stomach_pH | 0.67597457 |
| 164 | MP0002006_tumorigenesis | 0.67083922 |
| 165 | MP0002085_abnormal_embryonic_tissue | 0.65922577 |
| 166 | MP0002638_abnormal_pupillary_reflex | 0.65542514 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.65403753 |
| 168 | MP0002066_abnormal_motor_capabilities/c | 0.64432909 |
| 169 | MP0001664_abnormal_digestion | 0.63809430 |
| 170 | MP0008872_abnormal_physiological_respon | 0.63730034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.20850044 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.92449953 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.56171959 |
| 4 | Abnormality of glycolysis (HP:0004366) | 4.54438526 |
| 5 | Increased serum pyruvate (HP:0003542) | 4.54438526 |
| 6 | Progressive macrocephaly (HP:0004481) | 4.32333089 |
| 7 | Increased CSF lactate (HP:0002490) | 4.19567410 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.11101902 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 4.00773211 |
| 10 | Abnormality of the labia minora (HP:0012880) | 3.97393093 |
| 11 | Methylmalonic acidemia (HP:0002912) | 3.92086173 |
| 12 | Focal motor seizures (HP:0011153) | 3.90782760 |
| 13 | Acute encephalopathy (HP:0006846) | 3.90385788 |
| 14 | Atonic seizures (HP:0010819) | 3.85984649 |
| 15 | Abnormality of vitamin B metabolism (HP:0004340) | 3.76510169 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.72763432 |
| 17 | Hyperventilation (HP:0002883) | 3.62692520 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 3.54073453 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.47998113 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.43809768 |
| 21 | Methylmalonic aciduria (HP:0012120) | 3.29941064 |
| 22 | Febrile seizures (HP:0002373) | 3.26341627 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.25960099 |
| 24 | Neuroendocrine neoplasm (HP:0100634) | 3.21925979 |
| 25 | Hepatic necrosis (HP:0002605) | 3.18410932 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.15269922 |
| 27 | Hypothermia (HP:0002045) | 3.13641549 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07183489 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07183489 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.96488348 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.94780181 |
| 32 | Dialeptic seizures (HP:0011146) | 2.93169888 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.93144020 |
| 34 | Sensory axonal neuropathy (HP:0003390) | 2.91883145 |
| 35 | Bilateral microphthalmos (HP:0007633) | 2.90930399 |
| 36 | Increased hepatocellular lipid droplets (HP:0006565) | 2.90503272 |
| 37 | Increased serum lactate (HP:0002151) | 2.83847365 |
| 38 | Exercise intolerance (HP:0003546) | 2.77381975 |
| 39 | Respiratory failure (HP:0002878) | 2.74511918 |
| 40 | Pheochromocytoma (HP:0002666) | 2.72556476 |
| 41 | Ragged-red muscle fibers (HP:0003200) | 2.71499743 |
| 42 | Abnormal hair whorl (HP:0010721) | 2.69277373 |
| 43 | Neoplasm of the adrenal gland (HP:0100631) | 2.63381751 |
| 44 | Colon cancer (HP:0003003) | 2.62761485 |
| 45 | Absence seizures (HP:0002121) | 2.61491851 |
| 46 | Abnormality of vitamin metabolism (HP:0100508) | 2.61170903 |
| 47 | Failure to thrive in infancy (HP:0001531) | 2.60343017 |
| 48 | Abnormal pupillary function (HP:0007686) | 2.57634593 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55863117 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.47852320 |
| 51 | Hyperglycinemia (HP:0002154) | 2.45819693 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.45290898 |
| 53 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.45236506 |
| 54 | Lactic acidosis (HP:0003128) | 2.45174253 |
| 55 | Focal seizures (HP:0007359) | 2.42367908 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.42233385 |
| 57 | Abnormal protein glycosylation (HP:0012346) | 2.41031946 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.41031946 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.41031946 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.41031946 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.40865293 |
| 62 | Congenital primary aphakia (HP:0007707) | 2.39357292 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38700124 |
| 64 | Abnormality of glycine metabolism (HP:0010895) | 2.38700124 |
| 65 | Optic disc pallor (HP:0000543) | 2.38622693 |
| 66 | Palpitations (HP:0001962) | 2.37380476 |
| 67 | Emotional lability (HP:0000712) | 2.36304078 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.36018743 |
| 69 | Lipid accumulation in hepatocytes (HP:0006561) | 2.35645379 |
| 70 | Poor suck (HP:0002033) | 2.34685609 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.33742067 |
| 72 | Glycosuria (HP:0003076) | 2.33742067 |
| 73 | Abnormal lung lobation (HP:0002101) | 2.33196450 |
| 74 | Abnormality of methionine metabolism (HP:0010901) | 2.32611260 |
| 75 | Gait imbalance (HP:0002141) | 2.32421259 |
| 76 | Increased IgM level (HP:0003496) | 2.32353989 |
| 77 | Hypoglycemic coma (HP:0001325) | 2.25839780 |
| 78 | Megaloblastic anemia (HP:0001889) | 2.24259655 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22979840 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22979840 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22979840 |
| 82 | Cerebral hypomyelination (HP:0006808) | 2.22130011 |
| 83 | Posterior subcapsular cataract (HP:0007787) | 2.21689580 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21636780 |
| 85 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21452089 |
| 86 | Abnormal hemoglobin (HP:0011902) | 2.19082163 |
| 87 | Leukodystrophy (HP:0002415) | 2.17816848 |
| 88 | Limb dystonia (HP:0002451) | 2.16857990 |
| 89 | Tongue fasciculations (HP:0001308) | 2.16604610 |
| 90 | Nausea (HP:0002018) | 2.15593896 |
| 91 | Lethargy (HP:0001254) | 2.14449722 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.13991807 |
| 93 | Cerebral edema (HP:0002181) | 2.13569454 |
| 94 | Intestinal atresia (HP:0011100) | 2.12952732 |
| 95 | Neoplasm of the colon (HP:0100273) | 2.12893563 |
| 96 | Fat malabsorption (HP:0002630) | 2.11663867 |
| 97 | Multiple enchondromatosis (HP:0005701) | 2.11496775 |
| 98 | Aplastic anemia (HP:0001915) | 2.11213208 |
| 99 | Breast carcinoma (HP:0003002) | 2.11100399 |
| 100 | Abnormality of the anterior horn cell (HP:0006802) | 2.10168845 |
| 101 | Degeneration of anterior horn cells (HP:0002398) | 2.10168845 |
| 102 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08677474 |
| 103 | Poor head control (HP:0002421) | 2.07112920 |
| 104 | Horizontal nystagmus (HP:0000666) | 2.06298455 |
| 105 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.05886482 |
| 106 | Hypoplasia of the fovea (HP:0007750) | 2.05886482 |
| 107 | Exertional dyspnea (HP:0002875) | 2.05293427 |
| 108 | Rhabdomyosarcoma (HP:0002859) | 2.04699505 |
| 109 | Inability to walk (HP:0002540) | 2.02629068 |
| 110 | Myokymia (HP:0002411) | 2.02509745 |
| 111 | Ependymoma (HP:0002888) | 2.01372123 |
| 112 | Generalized tonic-clonic seizures (HP:0002069) | 2.01114760 |
| 113 | Hypobetalipoproteinemia (HP:0003563) | 2.00649042 |
| 114 | X-linked dominant inheritance (HP:0001423) | 1.98859518 |
| 115 | Abnormality of chromosome stability (HP:0003220) | 1.98666450 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 1.98564230 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98564230 |
| 118 | Ovarian neoplasm (HP:0100615) | 1.98539985 |
| 119 | Hyperglycinuria (HP:0003108) | 1.96543092 |
| 120 | Steatorrhea (HP:0002570) | 1.95220061 |
| 121 | Respiratory difficulties (HP:0002880) | 1.93706755 |
| 122 | Generalized hypotonia (HP:0001290) | 1.93451440 |
| 123 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91943286 |
| 124 | Cortical visual impairment (HP:0100704) | 1.91658921 |
| 125 | Upper limb muscle weakness (HP:0003484) | 1.90770899 |
| 126 | Meckel diverticulum (HP:0002245) | 1.90282772 |
| 127 | Renal cortical cysts (HP:0000803) | 1.90140138 |
| 128 | Recurrent abscess formation (HP:0002722) | 1.87926324 |
| 129 | Amblyopia (HP:0000646) | 1.87681906 |
| 130 | Abnormality of placental membranes (HP:0011409) | 1.85864895 |
| 131 | Amniotic constriction ring (HP:0009775) | 1.85864895 |
| 132 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.85655595 |
| 133 | Short tibia (HP:0005736) | 1.85527027 |
| 134 | Supernumerary spleens (HP:0009799) | 1.85428227 |
| 135 | Abnormality of the preputium (HP:0100587) | 1.85233227 |
| 136 | CNS demyelination (HP:0007305) | 1.84136557 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.82465036 |
| 138 | Muscle fibrillation (HP:0010546) | 1.82449412 |
| 139 | Biliary tract neoplasm (HP:0100574) | 1.82087932 |
| 140 | Duodenal stenosis (HP:0100867) | 1.81097886 |
| 141 | Small intestinal stenosis (HP:0012848) | 1.81097886 |
| 142 | Abnormality of the labia (HP:0000058) | 1.80430523 |
| 143 | Visual hallucinations (HP:0002367) | 1.80042023 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.78137267 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.78137267 |
| 146 | Delusions (HP:0000746) | 1.77561503 |
| 147 | Bradycardia (HP:0001662) | 1.77156878 |
| 148 | Symptomatic seizures (HP:0011145) | 1.77042865 |
| 149 | Hypoplastic female external genitalia (HP:0012815) | 1.76655965 |
| 150 | Gonadotropin excess (HP:0000837) | 1.76205486 |
| 151 | Agnosia (HP:0010524) | 1.74167990 |
| 152 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.74165968 |
| 153 | Labial hypoplasia (HP:0000066) | 1.71845605 |
| 154 | Abnormality of the duodenum (HP:0002246) | 1.71031497 |
| 155 | Abnormality of the ileum (HP:0001549) | 1.70781918 |
| 156 | Sparse eyelashes (HP:0000653) | 1.70411315 |
| 157 | Broad foot (HP:0001769) | 1.70395785 |
| 158 | Dyschromatopsia (HP:0007641) | 1.69690775 |
| 159 | Oral leukoplakia (HP:0002745) | 1.69605008 |
| 160 | Hypokinesia (HP:0002375) | 1.69313903 |
| 161 | Esotropia (HP:0000565) | 1.69310517 |
| 162 | Thyroid carcinoma (HP:0002890) | 1.67918067 |
| 163 | Papillary thyroid carcinoma (HP:0002895) | 1.67707553 |
| 164 | Nasolacrimal duct obstruction (HP:0000579) | 1.67578793 |
| 165 | Abnormality of the fovea (HP:0000493) | 1.67552647 |
| 166 | Single umbilical artery (HP:0001195) | 1.67174092 |
| 167 | Progressive inability to walk (HP:0002505) | 1.67120329 |
| 168 | Dysautonomia (HP:0002459) | 1.65672805 |
| 169 | Myositis (HP:0100614) | 1.65136338 |
| 170 | Resting tremor (HP:0002322) | 1.64637249 |
| 171 | Vertebral compression fractures (HP:0002953) | 1.63793643 |
| 172 | Polyphagia (HP:0002591) | 1.62761380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.59403807 |
| 2 | CASK | 4.21690635 |
| 3 | TRIM28 | 3.84907608 |
| 4 | GRK5 | 3.83892198 |
| 5 | ADRBK2 | 3.31816170 |
| 6 | CDK19 | 2.56063855 |
| 7 | SRPK1 | 2.46626341 |
| 8 | EIF2AK1 | 2.43786831 |
| 9 | NEK1 | 2.32562093 |
| 10 | TTK | 2.22561398 |
| 11 | GRK6 | 2.22540354 |
| 12 | RIPK4 | 2.14254607 |
| 13 | PLK3 | 2.11773275 |
| 14 | NUAK1 | 2.05388098 |
| 15 | STK16 | 2.03575477 |
| 16 | MKNK2 | 2.01531158 |
| 17 | MST4 | 1.98881329 |
| 18 | NTRK3 | 1.97751777 |
| 19 | GRK7 | 1.92227791 |
| 20 | NME1 | 1.86976862 |
| 21 | PLK4 | 1.78898610 |
| 22 | MAP4K2 | 1.72428128 |
| 23 | GRK1 | 1.69482497 |
| 24 | FRK | 1.68683379 |
| 25 | MAP2K7 | 1.67492630 |
| 26 | PIM2 | 1.66532060 |
| 27 | BRSK2 | 1.66087533 |
| 28 | ZAK | 1.65296488 |
| 29 | STK39 | 1.64453475 |
| 30 | CSF1R | 1.63110323 |
| 31 | SIK3 | 1.53265079 |
| 32 | NME2 | 1.50941356 |
| 33 | MATK | 1.49971841 |
| 34 | VRK2 | 1.49456608 |
| 35 | MKNK1 | 1.49356387 |
| 36 | AKT3 | 1.46418394 |
| 37 | BMPR2 | 1.44377749 |
| 38 | STK24 | 1.44263889 |
| 39 | BUB1 | 1.39029914 |
| 40 | EIF2AK3 | 1.38633595 |
| 41 | TNIK | 1.35348539 |
| 42 | ARAF | 1.31064999 |
| 43 | ADRBK1 | 1.29073977 |
| 44 | BMPR1B | 1.28509021 |
| 45 | BLK | 1.28487888 |
| 46 | FES | 1.27754242 |
| 47 | DAPK1 | 1.24542999 |
| 48 | PLK2 | 1.21518285 |
| 49 | MYLK | 1.21105562 |
| 50 | STK38L | 1.19243616 |
| 51 | MAP2K4 | 1.13265679 |
| 52 | MOS | 1.12635509 |
| 53 | TAF1 | 1.12408793 |
| 54 | TSSK6 | 1.11514045 |
| 55 | PLK1 | 1.09824509 |
| 56 | LIMK1 | 1.09230927 |
| 57 | CDC7 | 1.09026601 |
| 58 | CDK8 | 1.05889754 |
| 59 | MST1R | 1.03313942 |
| 60 | PRKG2 | 1.01243476 |
| 61 | NTRK1 | 0.94282396 |
| 62 | OXSR1 | 0.92119460 |
| 63 | WEE1 | 0.91688563 |
| 64 | TESK2 | 0.91441398 |
| 65 | CSNK1G1 | 0.88113494 |
| 66 | PTK2B | 0.86808237 |
| 67 | EPHA2 | 0.82019742 |
| 68 | TXK | 0.81545012 |
| 69 | PRPF4B | 0.81338611 |
| 70 | CSNK1G3 | 0.79186728 |
| 71 | MINK1 | 0.76436095 |
| 72 | PIK3CA | 0.76296900 |
| 73 | CSNK1G2 | 0.76234028 |
| 74 | PBK | 0.75131232 |
| 75 | TLK1 | 0.75084059 |
| 76 | WNK1 | 0.74951883 |
| 77 | BCR | 0.73298634 |
| 78 | VRK1 | 0.70370883 |
| 79 | PRKCI | 0.69834984 |
| 80 | ACVR1B | 0.69402806 |
| 81 | ERN1 | 0.68731790 |
| 82 | SYK | 0.68517952 |
| 83 | STK3 | 0.67835706 |
| 84 | PRKCG | 0.66721170 |
| 85 | IRAK3 | 0.64741115 |
| 86 | EIF2AK2 | 0.64207936 |
| 87 | TEC | 0.63376109 |
| 88 | SCYL2 | 0.63040230 |
| 89 | PDK3 | 0.62781594 |
| 90 | PDK4 | 0.62781594 |
| 91 | CAMK2B | 0.62205994 |
| 92 | BRSK1 | 0.60847216 |
| 93 | TNK2 | 0.60786857 |
| 94 | TESK1 | 0.60757824 |
| 95 | CCNB1 | 0.60565891 |
| 96 | CDK14 | 0.60489763 |
| 97 | KIT | 0.60059560 |
| 98 | DYRK3 | 0.59883652 |
| 99 | PRKCE | 0.57815539 |
| 100 | MAP3K4 | 0.57787903 |
| 101 | CDK18 | 0.57374470 |
| 102 | TGFBR2 | 0.56146974 |
| 103 | MAPKAPK5 | 0.55169243 |
| 104 | MUSK | 0.54877222 |
| 105 | PAK4 | 0.54523647 |
| 106 | YES1 | 0.54468819 |
| 107 | CAMKK2 | 0.54153819 |
| 108 | MET | 0.53871765 |
| 109 | FGFR2 | 0.53364516 |
| 110 | ERBB4 | 0.52776839 |
| 111 | PRKCD | 0.52370721 |
| 112 | CAMK2A | 0.51706987 |
| 113 | NEK6 | 0.51163111 |
| 114 | CDK15 | 0.50711880 |
| 115 | NEK9 | 0.50314915 |
| 116 | ERBB3 | 0.50086009 |
| 117 | IKBKB | 0.48906718 |
| 118 | CSNK1A1L | 0.48850322 |
| 119 | MAPK7 | 0.48696096 |
| 120 | FGFR1 | 0.46501721 |
| 121 | FER | 0.46361214 |
| 122 | RPS6KA4 | 0.45688813 |
| 123 | BCKDK | 0.45097570 |
| 124 | CDK11A | 0.44925399 |
| 125 | DAPK3 | 0.43771381 |
| 126 | MAP2K6 | 0.43633719 |
| 127 | AURKB | 0.43125987 |
| 128 | MAP3K9 | 0.42915495 |
| 129 | EPHA4 | 0.42882460 |
| 130 | LMTK2 | 0.41535422 |
| 131 | LYN | 0.41520956 |
| 132 | KSR1 | 0.41103748 |
| 133 | KDR | 0.40705605 |
| 134 | ATR | 0.40431553 |
| 135 | PAK3 | 0.40262204 |
| 136 | MAPK13 | 0.39895814 |
| 137 | CAMK4 | 0.39060473 |
| 138 | CSNK2A1 | 0.36965583 |
| 139 | FGR | 0.36798611 |
| 140 | ABL2 | 0.36020355 |
| 141 | LCK | 0.35635946 |
| 142 | TGFBR1 | 0.35605575 |
| 143 | IRAK4 | 0.35137132 |
| 144 | CDK9 | 0.34656868 |
| 145 | WNK3 | 0.34397102 |
| 146 | ATM | 0.34384671 |
| 147 | CHEK2 | 0.33226211 |
| 148 | DYRK2 | 0.33197554 |
| 149 | CAMK2D | 0.32889938 |
| 150 | PDK2 | 0.32792226 |
| 151 | CDK5 | 0.32622699 |
| 152 | BRAF | 0.32108090 |
| 153 | CSNK1A1 | 0.31009037 |
| 154 | CSNK2A2 | 0.30853282 |
| 155 | PNCK | 0.29531882 |
| 156 | MAP3K5 | 0.29359400 |
| 157 | PASK | 0.27137192 |
| 158 | RPS6KA5 | 0.26319541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.44835679 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.57615769 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.50130256 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.41785460 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.85552447 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.81639440 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.76482686 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.73377688 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.61883710 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.52788206 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.28347845 |
| 12 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.25737913 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.24615403 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11208907 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07716141 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.93546105 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91963746 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87005539 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.82732110 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73263221 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.69323324 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68021685 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66178125 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64973481 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.64077145 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62822827 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60391382 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58633196 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.55667925 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53589281 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52134461 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51257846 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.48761228 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43635740 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37509125 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.37183551 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35881928 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34959095 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.33243553 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26886776 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25644587 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24751628 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22732935 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21830588 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20052284 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19425562 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19325691 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.17295457 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 1.14423468 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.14258921 |
| 51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13158658 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13027140 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12348563 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11814940 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.10686135 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08937033 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.08881150 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.08131082 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08071365 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07012080 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06374666 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05653078 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05310600 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 1.03599588 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02887487 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02781036 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01715798 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00726020 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99887284 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99426371 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99411407 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97230299 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97183181 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96455540 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.96225316 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96090257 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95910780 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95221423 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95220727 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93821442 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92872786 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91147622 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90930727 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90320168 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89804364 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.89025290 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87826029 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87359811 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85323986 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85001247 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84863184 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84851258 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84770092 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84569931 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84225569 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83969650 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83905608 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83549171 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.82881570 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82862510 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82597572 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82466911 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.81374382 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | 0.81030566 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80055251 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78966967 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75719290 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75695153 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72931914 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72791773 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.71314478 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70490685 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.67666475 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66983479 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.66228043 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65668706 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65627446 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64407295 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63568173 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63495567 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62245045 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61648690 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60254453 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57946356 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57556843 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56234030 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54251832 |
| 128 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53824429 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53750428 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52286469 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52246969 |
| 132 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52113456 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.49305210 |
| 134 | Asthma_Homo sapiens_hsa05310 | 0.48696273 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.48547153 |
| 136 | Salmonella infection_Homo sapiens_hsa05132 | 0.46472932 |
| 137 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45892392 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.43309847 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42030601 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41693609 |
| 141 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41063429 |
| 142 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39586630 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38878932 |
| 144 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38747651 |
| 145 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38405910 |
| 146 | Renin secretion_Homo sapiens_hsa04924 | 0.38097286 |
| 147 | Salivary secretion_Homo sapiens_hsa04970 | 0.37527814 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36686978 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35826704 |
| 150 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34893964 |
| 151 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34854775 |
| 152 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34370756 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32799515 |
| 154 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32624559 |
| 155 | Shigellosis_Homo sapiens_hsa05131 | 0.32451567 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30689202 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29889287 |
| 158 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29693111 |
| 159 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28814423 |
| 160 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28801202 |
| 161 | Insulin secretion_Homo sapiens_hsa04911 | 0.28444804 |
| 162 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26094736 |
| 163 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25349402 |
| 164 | Homologous recombination_Homo sapiens_hsa03440 | 0.23613709 |
| 165 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23567209 |

